Same Drug Class

Ipilimumab vs Tamoxifen

Ipilimumab vs Tamoxifen: Overview

This comparison examines the pharmacological differences between Ipilimumab and Tamoxifen.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Tamoxifen: Selective estrogen receptor modulator (SERM).

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Tamoxifen — 5-7 days.

Chemical Properties

Molecular Formula: Tamoxifen — C26H29NO.

Molecular Weight: Tamoxifen — 371.5150 g/mol.

Type: Ipilimumab — Antibody; Tamoxifen — Small molecule.